Prot#CVT-301-004E: A 12-Month, Dose-Level Blinded Study Investigating the Safety and Efficacy of CVT-301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/5/15 → 1/5/18

Funding

  • INC Research, LLC (CVT-301-004E)
  • Civitas Therapeutics, Inc. (CVT-301-004E)